Key result
Antiplatelet agents manage arterial thrombosis but require balancing clinical benefits against bleeding risks and variable responses.
Design
Review
Authors
Loading...
Requires careful risk-benefit assessment in practice; reinforces consensus on antiplatelet utility but leaves open personalized strategies for bleeding and response variability.
Antiplatelet agents are essential for managing arterial thrombosis in cardiovascular and cerebrovascular diseases, though their use requires balancing efficacy with bleeding risks.
*Dr. Ankitkumar Merai 1Mr. Nishant Sarode (2026) studied this question. Antiplatelet agents effectively manage arterial thrombosis in cardiovascular diseases, but their clinical benefits must be balanced against bleeding risks and variable patient responses.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: